Global Brain has invested in Chefaa Inc. (Chefaa), an Egypt-based pharmacy benefits platform, through its GB-VII Growth Fund Investment Limited Partnership (GB-VII).
Chefaa is a patient-centric pharmacy benefits startup, which aims to manage chronic illness through a comprehensive approach and improve patients’ compliance through enhancing accessibility to medicine in Egypt. Since Egypt has been suffering from the unsustained access of medical supply particularly for chronic patients, Chefaa provides on-demand service from the nearest pharmacy just through uploading the prescription by patients.
Chefaa also provides the first Arabic speaking pharmaceutical blog as well as 24/7 pharmaceutical consultation as a freemium service to improve the pharmaceutical literacy in Egypt. They are expecting to expand their business in the MENA (Middle East & North Africa) region led by starting the business operation in Saudi Arabia.
Global Brain sees a significant opportunity in the growth of the e-pharmacy industry in the MENA region headed by strong entrepreneurs with vast field experiences.
- Doaa Aref
- GB-VII Growth Fund Investment Limited Partnership
- General Partner
- Global Brain Corporation
About Global Brain
- Tokyo, Japan
- Yasuhiko Yurimoto
- January 1998